Literature DB >> 15507437

Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA.

Wei-Wen Ge1, Weiyan Wen, Wendy Strong, Cheryl Leystra-Lantz, Michael J Strong.   

Abstract

The mechanism by which mutated copper-zinc superoxide dismutase (SOD1) causes familial amyotrophic lateral sclerosis is believed to involve an adverse gain of function, independent of the physiological antioxidant enzymatic properties of SOD1. In this study, we have observed that mutant SOD1 (G41S, G85A, and G93A) but not the wild type significantly reduced the stability of the low molecular weight neurofilament mRNA in a dosage-dependent manner. We have also demonstrated that mutant SOD1 but not the wild type bound directly to the neurofilament mRNA 3'-untranslated region and that the binding was necessary to induce mRNA destabilization. These observations provide an explanation for a novel gain of function in which mutant SOD1 expression in motor neurons alters an intermediate filament protein expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507437     DOI: 10.1074/jbc.M405065200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain.

Authors:  Reza Pourhaghighi; Peter E A Ash; Sadhna Phanse; Florian Goebels; Lucas Z M Hu; Siwei Chen; Yingying Zhang; Shayne D Wierbowski; Samantha Boudeau; Mohamed T Moutaoufik; Ramy H Malty; Edyta Malolepsza; Kalliopi Tsafou; Aparna Nathan; Graham Cromar; Hongbo Guo; Ali Al Abdullatif; Daniel J Apicco; Lindsay A Becker; Aaron D Gitler; Stefan M Pulst; Ahmed Youssef; Ryan Hekman; Pierre C Havugimana; Carl A White; Benjamin C Blum; Antonia Ratti; Camron D Bryant; John Parkinson; Kasper Lage; Mohan Babu; Haiyuan Yu; Gary D Bader; Benjamin Wolozin; Andrew Emili
Journal:  Cell Syst       Date:  2020-04-22       Impact factor: 10.304

3.  Divalent-metal-dependent nucleolytic activity of Cu, Zn superoxide dismutase.

Authors:  Wei Jiang; Tao Shen; Yingchun Han; Qunhui Pan; Changlin Liu
Journal:  J Biol Inorg Chem       Date:  2006-06-28       Impact factor: 3.358

Review 4.  PARP overactivation in neurological disorders.

Authors:  Vijay Kumar Arruri; Chayanika Gundu; Islauddin Khan; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Mol Biol Rep       Date:  2021-03-25       Impact factor: 2.316

5.  DNA-triggered aggregation of copper, zinc superoxide dismutase in the presence of ascorbate.

Authors:  Jun Yin; Si Hu; Wei Jiang; Liang Liu; Shemin Lan; Xuegang Song; Changlin Liu
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

6.  Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.

Authors:  Blaine R Roberts; John A Tainer; Elizabeth D Getzoff; Dean A Malencik; Sonia R Anderson; Valerie C Bomben; Kathrin R Meyers; P Andrew Karplus; Joseph S Beckman
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

Review 7.  TDP-43 in neurodegenerative disorders.

Authors:  Casey Cook; Yong-jie Zhang; Ya-fei Xu; Dennis W Dickson; Leonard Petrucelli
Journal:  Expert Opin Biol Ther       Date:  2008-07       Impact factor: 4.388

Review 8.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Authors:  Stacey A Sakowski; Adam D Schuyler; Eva L Feldman
Journal:  Amyotroph Lateral Scler       Date:  2009-04

9.  Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.

Authors:  J Simon Lunn; Stacey A Sakowski; Bhumsoo Kim; Andrew A Rosenberg; Eva L Feldman
Journal:  Dev Neurobiol       Date:  2009-11       Impact factor: 3.964

Review 10.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.